ATE418548T1 - Substituierte 3-cyanothiophen acetamide als glucagon receptor antagonisten - Google Patents

Substituierte 3-cyanothiophen acetamide als glucagon receptor antagonisten

Info

Publication number
ATE418548T1
ATE418548T1 AT04726965T AT04726965T ATE418548T1 AT E418548 T1 ATE418548 T1 AT E418548T1 AT 04726965 T AT04726965 T AT 04726965T AT 04726965 T AT04726965 T AT 04726965T AT E418548 T1 ATE418548 T1 AT E418548T1
Authority
AT
Austria
Prior art keywords
glucagon receptor
cyanothiophene
acetamide
substituted
receptor antagonists
Prior art date
Application number
AT04726965T
Other languages
English (en)
Inventor
Shawn ERICKSON
Paul Gillespie
Kevin Guertin
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE418548T1 publication Critical patent/ATE418548T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
AT04726965T 2003-04-16 2004-04-13 Substituierte 3-cyanothiophen acetamide als glucagon receptor antagonisten ATE418548T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46320003P 2003-04-16 2003-04-16

Publications (1)

Publication Number Publication Date
ATE418548T1 true ATE418548T1 (de) 2009-01-15

Family

ID=33300050

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04726965T ATE418548T1 (de) 2003-04-16 2004-04-13 Substituierte 3-cyanothiophen acetamide als glucagon receptor antagonisten

Country Status (15)

Country Link
US (1) US7138529B2 (de)
EP (1) EP1620425B1 (de)
JP (1) JP4599347B2 (de)
KR (1) KR100779324B1 (de)
CN (1) CN100398533C (de)
AT (1) ATE418548T1 (de)
AU (1) AU2004230220B2 (de)
BR (1) BRPI0409454A (de)
CA (1) CA2521732C (de)
DE (1) DE602004018630D1 (de)
ES (1) ES2316978T3 (de)
MX (1) MXPA05010998A (de)
PL (1) PL1620425T3 (de)
RU (1) RU2336274C2 (de)
WO (1) WO2004092156A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2818547B1 (fr) * 2000-12-22 2006-11-17 Oreal Nouveaux derives c-glycosides et utilisation
CA2498106A1 (en) * 2002-09-12 2004-03-25 Merck & Co., Inc. Substituted bicyclic thiophene derivatives, compositions containing such compounds and methods of use
US20050085531A1 (en) * 2003-10-03 2005-04-21 Hodge Carl N. Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
ES2309765T3 (es) * 2004-05-28 2008-12-16 4Sc Ag Tetrahidropiridotiofenos.
DE602005007220D1 (de) 2004-06-04 2008-07-10 Nycomed Gmbh Tetrahydropyridothiophenen zur verwendung in der behandlung von krebs
US7714134B2 (en) * 2004-06-11 2010-05-11 4Sc Ag Compounds and use of tetrahydropyridothiophenes
US20090209534A1 (en) * 2004-06-11 2009-08-20 Klaus Pekari Novel compounds and use of tetrahydropyridopyridothiophenes
DE102004051188A1 (de) * 2004-10-21 2006-04-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Cyanothiophene, deren Herstellung und deren Verwendung als Arzneimittel
AU2006212224A1 (en) * 2005-02-09 2006-08-17 4Sc Ag Tetrahydropyridothiophenes for the treatment of proliferative diseases such as cancer
US7741488B2 (en) * 2005-02-11 2010-06-22 4Sc Ag Tetrahydropyridothiophenes as antiproliferative agents for the treatment of cancer
US20090252706A1 (en) * 2005-02-11 2009-10-08 Klaus Pekari Tetrahydropyridothiophenes As Antripoliferative Agents For The Treatment Of Cancer
CA2609003A1 (en) * 2005-05-25 2006-11-30 Nycomed Gmbh Tetrahydropyridothiophenes for use in the treatment of cancer
US7763728B2 (en) * 2005-05-25 2010-07-27 4Sc Ag Tetrahydropyridothiophenes
AU2008212816B2 (en) * 2007-02-09 2014-08-07 Metabasis Therapeutics, Inc. Novel antagonists of the glucagon receptor
FR2921367B1 (fr) * 2007-09-26 2009-10-30 Servier Lab Nouveau procede de synthese du ranelate de strontium et de ses hydrates
EP2326618B1 (de) 2008-08-13 2014-10-15 Metabasis Therapeutics, Inc. Glucagon-antagonisten
SG191040A1 (en) 2010-12-23 2013-08-30 Pfizer Glucagon receptor modulators
PE20140253A1 (es) 2011-02-08 2014-03-09 Pfizer Moduladores del receptor de glucagon
EP2734503B1 (de) 2011-07-22 2015-09-16 Pfizer Inc. Chinolinylglucagonrezeptor- modulatoren
WO2015191900A1 (en) 2014-06-12 2015-12-17 Ligand Pharmaceuticals, Inc. Glucagon antagonists
US11427600B2 (en) 2014-06-27 2022-08-30 Nogra Pharma Limited Aryl receptor modulators and methods of making and using the same
AU2019291488B2 (en) * 2018-06-19 2022-02-24 Novartis Ag N-substituted tetrahydrothienopyridine derivatives and uses thereof
CN114957278B (zh) * 2021-02-20 2023-08-11 兰州大学 胰高血糖素受体拮抗剂及其用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206375A (en) * 1985-03-02 1993-04-27 Basf Aktiengesellschaft Thiophene derivatives
DE4236400A1 (de) * 1992-10-28 1994-05-05 Bayer Ag N-Phenylacetaminonitrile
AU7186494A (en) * 1993-07-02 1995-01-24 Bayer Aktiengesellschaft Substituted spiroheterocyclic 1h-3-arylpyrrolidine-2,4-dione derivatives, methods of preparing them and their use as pest-control agents
WO1998040385A1 (en) 1997-03-07 1998-09-17 Novo Nordisk A/S 4,5,6,7-TETRAHYDRO-THIENO[3,2-c]PYRIDINE DERIVATIVES, THEIR PREPARATION AND USE
WO1999046267A1 (en) 1998-03-12 1999-09-16 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (ptpases)
WO2000014090A1 (en) 1998-09-02 2000-03-16 Novo Nordisk A/S 4,5,6,7-tetrahydro-thieno[2,3-c]pyridine derivatives
US20020045613A1 (en) * 2000-04-27 2002-04-18 Heinz Pauls 1-aroyl-piperidinyl benzamidines
GB0114185D0 (en) * 2001-06-12 2001-08-01 Protherics Molecular Design Lt Compounds
WO2002083649A1 (fr) * 2001-04-11 2002-10-24 Senju Pharmaceutical Co., Ltd. Nouveaux derives d'imidazolidinedione et leur utilisation comme medicament
EP1383771A1 (de) * 2001-04-20 2004-01-28 Vertex Pharmaceuticals Incorporated 9-deazaguaninderivate als gsk-3 inhibitoren
CA2498106A1 (en) 2002-09-12 2004-03-25 Merck & Co., Inc. Substituted bicyclic thiophene derivatives, compositions containing such compounds and methods of use
WO2004024066A2 (en) 2002-09-12 2004-03-25 Merck & Co., Inc. Method of treating diabetes and related conditions
US7196106B2 (en) * 2002-11-05 2007-03-27 Merck & Co., Inc Cyanothiophene derivatives, compositions containing such compounds and methods of use

Also Published As

Publication number Publication date
CA2521732C (en) 2011-06-07
EP1620425A1 (de) 2006-02-01
AU2004230220A1 (en) 2004-10-28
CN100398533C (zh) 2008-07-02
US7138529B2 (en) 2006-11-21
RU2336274C2 (ru) 2008-10-20
CN1774433A (zh) 2006-05-17
CA2521732A1 (en) 2004-10-28
ES2316978T3 (es) 2009-04-16
KR20060011959A (ko) 2006-02-06
MXPA05010998A (es) 2005-12-12
BRPI0409454A (pt) 2006-05-02
EP1620425B1 (de) 2008-12-24
WO2004092156A1 (en) 2004-10-28
KR100779324B1 (ko) 2007-11-28
JP2006523641A (ja) 2006-10-19
US20040209943A1 (en) 2004-10-21
PL1620425T3 (pl) 2009-06-30
DE602004018630D1 (en) 2009-02-05
JP4599347B2 (ja) 2010-12-15
AU2004230220B2 (en) 2009-09-17
RU2005135338A (ru) 2007-05-27

Similar Documents

Publication Publication Date Title
ATE418548T1 (de) Substituierte 3-cyanothiophen acetamide als glucagon receptor antagonisten
ATE482210T1 (de) Oxadiazolderivate als s1p1-rezeptor-agonisten
ATE384050T1 (de) Benzazepinderivate als histamin-h3-antagonisten
NO20083427L (no) Cystoksiske midler omfattende nye tomaymycinderivater og deres terapeutiske anvendelse
DE602007007614D1 (de) Substituierte pyrrolidinone als hemmer von 11-beta-hydroxysteroiddehydrogenase 1
ATE478856T1 (de) Spirobenzodioxole und deren verwendung als cb1- antagonisten
ECSP066886A (es) Compuestos y métodos para el tratamiento de dislipidemia
ATE446962T1 (de) Thiazolopyridinon-derivate als mch- rezeptorantagonisten
IS8503A (is) Azatvíhringja heteróhringir sem kannabínóníð-viðtakastillar
ATE483707T1 (de) 2-cyclopropylthiazolderivate
MX2009005363A (es) Pirimidinas y su uso como antagonistas del receptor cxcr2.
DE602005027230D1 (de) Cgrp-rezeptorantagonisten
ATE466860T1 (de) Cgrp-rezeptorantagonisten
DE602005023197D1 (de) -muscarinrezeptors
DK1828177T3 (da) Hidtil ukendte MCH-receptorantagonister
ATE484505T1 (de) 5-sulfanylmethylä1,2,4ütriazolä1,5-aüpyrimidin- - olderivate als cxcr2-antagonisten
MX2009005358A (es) Derivados de 5-sulfanilmetil-pirazolo[1,5-a]pirimidin-7-ol como antagonistas de cxcr2.
ATE553106T1 (de) Heteroarylpyrrolopyridinone als kinaseinhibitoren
ATE384058T1 (de) Thiazolderivate
EA200970302A1 (ru) Тиофенпиразолопиримидиновые соединения
ATE475645T1 (de) Pyrrolidinderivate als doppelte nk1/nk3- rezeptorenantagonisten
ATE466842T1 (de) 3-substituierte pyridinderivate als h3- antagonisten
CY1109808T1 (el) Αρυλινδενο-πυριδινες και αρυλινδενο-πυριμιδινες και η χρηση τους ως ανταγωνιστων των υποδοχεων αδενοσινης α2α
ATE467636T1 (de) Pyrazoloä3 , 4-düazepinderivate als histamin-h3- antagonisten
EA200501595A1 (ru) Азабициклические производные в качестве антагонистов мускаринового рецептора

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1620425

Country of ref document: EP